Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high risk smoldering multiple myeloma included in the GEM-CESAR trial

Autor: Noemí Puig, Cristina Agulló, Teresa Contreras, José-Juan Pérez, Irene Aires, María-José Calasanz, Ramón García-Sanz, Sergio Castro, Joaquín Martínez-López, Paula Rodríguez-Otero, Verónica González-Calle, Marta S González, Albert Oriol, Norma C Gutiérrez, Rafael Ríos-Tamayo, Laura Rosiñol, Miguel-Ángel Álvarez, Joan Bargay, Ana-Pilar González-Rodríguez, Adrián Alegre, Fernando Escalante, María-Belén Iñigo, Javier de la Rubia, Ana-Isabel Teruel, Felipe de Arriba, Luis Palomera, Miguel T Hernández, Javier López-Jiménez, Marta Reinoso, Aránzazu García-Mateo, Enrique M Ocio, Joan Bladé, Juan-José Lahuerta, María-Teresa Cedena, Bruno Paiva, Jesús F San Miguel, María-Victoria Mateos

Publikováno v: Haematologica, Vol 999, Iss 1 (2024)

The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein is being investigated in patients with monoclonal gammopathies but no data are yet available in high-risk smoldering myeloma (HRsMM). We have therefore

Externí odkaz: https://doaj.org/article/c81a444b8f6e434cb89c96b45ea2aec6

A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma

Autor: Cristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, Laura Rosiñol, María-Jesús Blanchard, José-María Bellón, Ramón García-Sanz, Javier de la Rubia, Ana López de la Guía, Ana Jímenez-Ubieto, Isidro Jarque, Belén Iñigo, Victoria Dourdil, Felipe de Arriba, Clara Cuéllar Pérez-Ávila, Yolanda Gonzalez, Miguel-Teodoro Hernández, Joan Bargay, Miguel Granell, Paula Rodríguez-Otero, Maialen Silvent, Carmen Cabrera, Rafael Rios, Adrián Alegre, Mercedes Gironella, Marta-Sonia Gonzalez, Anna Sureda, Antonia Sampol, Enrique M. Ocio, Isabel Krsnik, Antonio García, Aránzazu García-Mateo, Joan-Alfons Soler, Jesús Martín, José-María Arguiñano, María-Victoria Mateos, Joan Bladé, Jesús F. San-Miguel, Juan-José Lahuerta, Joaquín Martínez-López, GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group

Publikováno v: Blood Cancer Journal, Vol 12, Iss 4, Pp 1-8 (2022)

Abstract Infections remain a common complication in patients with multiple myeloma (MM) and are associated with morbidity and mortality. A risk score to predict the probability of early severe infection could help to identify the patients that would

Externí odkaz: https://doaj.org/article/fcb4c3d2e7254e4d93afeee7eb8db18a

Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Post-Hoc Analysis of Sustained Undetectable Measurable Residual Disease (MRD)

Autor: Maria-Victoria Mateos, Joaquín Martínez-López, Paula Rodríguez-Otero, Jesús San-Miguel, Veronica Gonzalez-Calle, Marta Sonia Gonzalez, Albert Oriol, Norma C. Gutierrez, Rafael Rios, Laura Rosinol Dachs, Miguel Angel Alvarez, Joan Bargay, Ana Pilar Gonzalez, Fernando Escalante, Adrian Alegre, Belén Iñigo, Javier de la Rubia, Ana Isabel Teruel, Felipe De Arriba, Luis Palomera, Miguel-Teodoro Hernández, Javier Lopez Jimenez, Marta Reinoso Segura, Aránzazu García Mateo, Enrique M. Ocio, Joan Bladé, Juan-José Lahuerta, María Teresa Cedena, Noemi Puig, Bruno Paiva

Publikováno v: Blood. 140:292-294

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7dcddca02e6343e6e078dd3b189fe3b7
https://doi.org/10.1182/blood-2022-159606

Clinical management and follow-up of relapsed immune thrombotic thrombocytopenic purpura during pregnancy: A case report

Autor: Sandra Valencia Castillo, Esther Zato Hernández, M Dolores Llorente Melgar, M Carmen Olivier Cornacchia, José Díaz Valdés, Aránzazu García Mateo, José Antonio Queizán Hernández, Ana Torres Tienza, Shally Marcellini Antonio

Publikováno v: Thrombosis Research. 194:91-94

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ff77c33794cc98282b0a518066fd68a
https://doi.org/10.1016/j.thromres.2020.06.020

B-cell regeneration profile and minimal residual disease status in bone marrow of treated multiple myeloma patients

Autor: Carlos Aguilar, Angelo Maiolino, Aránzazu García-Mateo, Carmen Aguilera-Sanz, Alba Corral-Mateos, Maria-Victoria Mateos, Abelardo Bárez, Omar García-Sánchez, Anna Beatriz Salgado, Vincent H.J. van der Velden, Jeroen G. te Marvelde, José Pérez-Morán, Alberto Orfao, Pilar Leoz, Leire Burgos, Juan Flores-Montero, Jacques J.M. van Dongen, Jorge Labrador, Bruno Paiva, Roberto José Pessoa Magalhães, Elaine Sobral da Costa, Noemi Puig, Brian G.M. Durie, Roberia Pontes, Luzalba Sanoja-Flores

Publikováno v: Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Cancers
Digital.CSIC. Repositorio Institucional del CSIC
Cancers, 13(7):1704. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(7). MDPI
Cancers, Vol 13, Iss 1704, p 1704 (2021)
Cancers; Volume 13; Issue 7; Pages: 1704

© 2021 by the authors.
B-cell regeneration during therapy has been considered as a strong prognostic factor in multiple myeloma (MM). However, the effects of therapy and hemodilution in bone marrow (BM) B-cell recovery have not been systematica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e22ebb527a9fc805c4a59029b611aa4
https://hdl.handle.net/10171/61229